Priority Date: 07.06.12 (CN 20121185089)

POLYPEPTIDE WITH FUNCTION OF SYNERGISTIC TARGETED DIAGNOSIS AND THERAPY OF NASOPHARYNGEAL CARCINOMA, NANOPARTICLES CARRYING SAME AND USE THEREOF

  • Application ID: EP13801389
  • Status: EXAMINATION IN PROGRESS

Applicant

Attorney

Employment test 11 - 50 employees
Company dna kador and partner
operating since 1974
Headquarter in Munich and 3 offices
active in Legal Services, IP Consulting, and IP-related Communication Service

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 07.06.2012 - Priority Date (CN 20121185089)
  • 12.12.2013 - Publication A1 (WO2013181934)
  • 15.04.2015 - Publication A1 (EP2860193)